ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 35 filers reported holding ATYR PHARMA INC in Q3 2022. The put-call ratio across all filers is 5.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,015 | -63.5% | 189,250 | -50.0% | 0.00% | -50.0% |
| Q2 2023 | $818,316 | +153.9% | 378,850 | +146.9% | 0.00% | +100.0% |
| Q1 2023 | $322,245 | -5.8% | 153,450 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $341,969 | -37.7% | 156,150 | -14.7% | 0.00% | -50.0% |
| Q3 2022 | $549,000 | +5.4% | 183,150 | -0.4% | 0.00% | +100.0% |
| Q2 2022 | $521,000 | -50.7% | 183,950 | -6.9% | 0.00% | -66.7% |
| Q1 2022 | $1,057,000 | -63.5% | 197,550 | -49.0% | 0.00% | -57.1% |
| Q4 2021 | $2,894,000 | -33.9% | 387,352 | -19.7% | 0.01% | -36.4% |
| Q3 2021 | $4,381,000 | +648.9% | 482,450 | +302.2% | 0.01% | +450.0% |
| Q2 2021 | $585,000 | +828.6% | 119,950 | +750.7% | 0.00% | – |
| Q1 2021 | $63,000 | -80.9% | 14,100 | -83.4% | 0.00% | -100.0% |
| Q4 2020 | $330,000 | -39.2% | 84,950 | -49.5% | 0.00% | -50.0% |
| Q3 2020 | $543,000 | +51.3% | 168,250 | +107.8% | 0.00% | +100.0% |
| Q2 2020 | $359,000 | +252.0% | 80,950 | +122.7% | 0.00% | – |
| Q1 2020 | $102,000 | – | 36,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|